1 Min Read
May 25 (Reuters) - Hovione
* Hovione announces start of Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.